Contraception News and Research

Latest Contraception News and Research

More women using ‘morning after’ pill

Figures have revealed that the rate of women using emergency contraception in 2006-08 more than doubled, compared with the rate in the previous four to six years, before the pills were approved for use without a prescription. This comes from a study from the Guttmacher Institute.

29 Apr 2011

Menstruation raises risk of injuries while pills protect: Study

Scientists have found that a woman's risk of injuring her knees, feet and ankles is significantly heightened at the beginning and middle of her period. But the risk is low for women on contraceptive pills they say.

28 Apr 2011

Newer birth control pill raises risk of blood clots

Two human trials in the US and the UK including women from both populations showed that women taking newer forms of oral contraceptives, which include drosperinone, a synthetic version of the hormone progesterone, increased their risk of developing a blood clots by two or three times over those taking older birth control pills that rely on a different form of the hormone known as levonorgestrel.

26 Apr 2011

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Bayer HealthCare Pharmaceuticals, Inc. is aware of two studies published today in The British Medical Journal, ONLINE FIRST.

25 Apr 2011

Viewpoints: Medicare cuts & partisan politics; Colorado health exchange; NEJM on family planning

The debate over Paul Ryan's Medicare reform ideas has largely been healthy, even amid the liberal distortions. But why has there been so little scrutiny of President Obama's new Medicare proposal? Anyone worrying about more individual choice and responsibility in health care might be interested to learn that the alternative is turning every one of these decisions over to a 15-member central committee.

22 Apr 2011

Contraception drospirenone raises risk for blood clots

Two new drug safety studies conducted by researchers at Boston University School of Medicine (BUSM) provide strong evidence that women taking oral contraception with drospirenone have an increased risk of nonfatal venous thromboembolism, or blood clots, compared to women taking oral contraception with levonorgestrel.

21 Apr 2011

African AIDS drug trial stopped prematurely

One of the studies in three African countries where women were given an AIDS drug to prevent HIV infection is being stopped because the project is not working, researchers said Monday. These women on the trial were taking a daily dose of the drug Truvada or a look-alike placebo pill and had an equal chance of becoming infected. The ones taking Truvada were expected to have had a much lower infection rate.

19 Apr 2011

Congress approves current-year spending plan, votes on defunding health law as part of agreement

Separate measures to defund the health law and Planned Parenthood, which were voted on as part of the compromise that enabled the broader spending bill to move to a vote in both chambers, were approved in the House but defeated in the Senate.

16 Apr 2011

Ortho-McNeil Neurologics announces voluntary recall of TOPAMAX 100mg Tablets

Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets. These two lots were shipped between 10/19/2010 and 12/28/2010 and distributed in the U.S. and Puerto Rico.

15 Apr 2011

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

15 Apr 2011

Roundup: Minn. insurers to return profits above 1% from state plans; Fla. Medicaid managed care costs questioned

In part of the continuing change to Minnesota's business with health insurance plans, the state announced Tuesday that four major health plans agreed to a 1 percent cap on their profits on state business. The one-cap means that the plans -- BlueCross BlueShield, HealthPartners, Medica, and UCare -- will return any profit above 1 percent to the state next April.

7 Apr 2011

First Editon: April 6, 2011

Today's headlines include stories and analysis of how the Ryan budget plan would change Medicare, Medicaid and the shape of the federal government.

6 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

Study finds increased risk of VTE during first year of combination oral contraceptive usage

Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk in women who use combination oral contraceptives (COCs), also known as "the Pill".

25 Mar 2011

Medical experts: Nation needs to offer more confidential care for sexually active teens

After reviewing existing research regarding the common practices of health care providers who see adolescent patients across the country, Rebecca Allen, MD, MPH, a clinician and researcher at Women & Infants Hospital of Rhode Island, and her colleague, Michelle Forcier, MD, MPH, an adolescent medicine specialist at Hasbro Children's Hospital, asserted that the nation needs to offer more confidential care for teenagers who are sexually active.

25 Mar 2011

Viewpoints: Too many CT scans; single payer is 'best solution'; WSJ on Wash. state 'overregulation'

Studies indicate patients are receiving more CT scans than ever before in emergency rooms, hospitals and outpatient settings. This burgeoning application of CT scanning has important implications for patients, diagnostically and in terms of radiation exposure, as well as consequences for the country's overall medical budget.

19 Mar 2011

EMA CHMP adopts positive opinion for Teva's NOMAC-E2 contraceptive pill

Teva Pharmaceutical Industries Ltd. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for NOMAC-E2, an investigational contraceptive pill combining 1.5 mg of 17-beta-estradiol with 2.5 mg of nomegestrol acetate in a 24/4 monophasic regimen.

18 Mar 2011

Research highlights new parameters for HIV study

A research article co-authored by Brenna Anderson, MD, director of Reproductive Infectious Diseases Consultation in the Division of Maternal-Fetal Medicine at Women & Infants Hospital of Rhode Island, was included in the recently published special issue of the American Journal of Reproductive Immunology.

17 Mar 2011

Viewpoints: Are waivers weakening health law?; Ill. 'Dangerous Docs'; Arizona transplants

It is irresponsible for the feds to dole out hundreds of millions without the assurance of insurance, payment and system reform, as well as universal coverage. That's the problem with Republican proposals to use a "block grant" approach in giving Medicaid dollars to the states to do with as they will. The president should use his precious time to encourage the law's implementation as soon as possible in areas of the country that are already on this road -- like our own Upper Midwest -- not to coddle his political enemies.

9 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

Contraception News and Research

Latest Contraception News and Research

More women using ‘morning after’ pill

Menstruation raises risk of injuries while pills protect: Study

Newer birth control pill raises risk of blood clots

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Viewpoints: Medicare cuts & partisan politics; Colorado health exchange; NEJM on family planning

Contraception drospirenone raises risk for blood clots

African AIDS drug trial stopped prematurely

Congress approves current-year spending plan, votes on defunding health law as part of agreement

Ortho-McNeil Neurologics announces voluntary recall of TOPAMAX 100mg Tablets

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Roundup: Minn. insurers to return profits above 1% from state plans; Fla. Medicaid managed care costs questioned

First Editon: April 6, 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Study finds increased risk of VTE during first year of combination oral contraceptive usage

Medical experts: Nation needs to offer more confidential care for sexually active teens

Viewpoints: Too many CT scans; single payer is 'best solution'; WSJ on Wash. state 'overregulation'

EMA CHMP adopts positive opinion for Teva's NOMAC-E2 contraceptive pill

Research highlights new parameters for HIV study

Viewpoints: Are waivers weakening health law?; Ill. 'Dangerous Docs'; Arizona transplants

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in